VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Saturday, January 3, 2026
Stock Comparison
CAR Group Limited vs Edwards Lifesciences Corporation
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
CAR Group Limited
CAR · ASX
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into CAR Group Limited's moat claims, evidence, and risks.
View CAR analysisEdwards Lifesciences Corporation
EW · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Edwards Lifesciences Corporation's moat claims, evidence, and risks.
View EW analysisComparison highlights
- Moat score gap: Edwards Lifesciences Corporation leads (82 / 100 vs 69 / 100 for CAR Group Limited).
- Segment focus: CAR Group Limited has 5 segments (41% in Australia); Edwards Lifesciences Corporation has 3 segments (75.5% in Transcatheter Aortic Valve Replacement (TAVR)).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: CAR Group Limited has 6 moat types across 3 domains; Edwards Lifesciences Corporation has 6 across 3.
Primary market context
CAR Group Limited
Australia
Online vehicle marketplace, dealer advertising & automotive data/services
Australia
Dealers, OEM advertisers, private sellers & buyers
Two-sided marketplace + advertising + data/SaaS tools
41%
Edwards Lifesciences Corporation
Transcatheter Aortic Valve Replacement (TAVR)
Transcatheter aortic valve replacement (TAVR) devices
Global
Hospitals and structural heart centers
Medical device manufacturer
75.5%
Side-by-side metrics
Moat coverage
Shared moat types
CAR Group Limited strengths
Edwards Lifesciences Corporation strengths
Segment mix
CAR Group Limited segments
Full profile >Australia
Oligopoly
North America
Oligopoly
Latin America
Oligopoly
Asia
Oligopoly
Investments
Competitive
Edwards Lifesciences Corporation segments
Full profile >Transcatheter Aortic Valve Replacement (TAVR)
Oligopoly
Transcatheter Mitral and Tricuspid Therapies (TMTT)
Competitive
Surgical Structural Heart
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.